Plasma Treatment

PRP or platelet-rich plasma is a perfect mix of the stem cells and growth factors that are made from your own blood. It not only boosts new hair growth but also stops the active hair fall.

Covid treatments using plasma taken from the blood of recovered coronavirus patients should not be given to people with mild or moderate illness, the World Health Organization said Tuesday.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Maharashtra Chief Minister Uddhav Thackeray on Sunday inaugurated a plasma treatment centre in Ratnagiri, over 340 kilometres from Mumbai, at an e-function.

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays.

Union Minister Dharmendra Pradhan on Saturday donated his plasma at SCB Medical College and Hospital in Cuttack for treatment of critical COVID-19 patients.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

Markets worldwide were boosted after US regulators on Sunday authorised the use of blood plasma from recovered COVID-19 patients as a treatment option.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

Asian shares advanced for a second straight session on Monday, underpinned by hopes of recovery from coronavirus after the US Food & Drug Administration (FDA) authorised the use of blood plasma from recovered patients as a treatment option.

American authorities announced on Sunday an emergency approval of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US.

At a time when the state health department is facing a crunch of plasma for the treatment of COVID-19 patients, 67 cops of Assam Police, who have been cured of coronavirus, have volunteered to donate plasma.

PRP or platelet-rich plasma is a perfect mix of the stem cells and growth factors that are made from your own blood. It not only boosts new hair growth but also stops the active hair fall.

Covid treatments using plasma taken from the blood of recovered coronavirus patients should not be given to people with mild or moderate illness, the World Health Organization said Tuesday.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Maharashtra Chief Minister Uddhav Thackeray on Sunday inaugurated a plasma treatment centre in Ratnagiri, over 340 kilometres from Mumbai, at an e-function.

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays.

Union Minister Dharmendra Pradhan on Saturday donated his plasma at SCB Medical College and Hospital in Cuttack for treatment of critical COVID-19 patients.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

Markets worldwide were boosted after US regulators on Sunday authorised the use of blood plasma from recovered COVID-19 patients as a treatment option.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

Asian shares advanced for a second straight session on Monday, underpinned by hopes of recovery from coronavirus after the US Food & Drug Administration (FDA) authorised the use of blood plasma from recovered patients as a treatment option.

American authorities announced on Sunday an emergency approval of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US.

At a time when the state health department is facing a crunch of plasma for the treatment of COVID-19 patients, 67 cops of Assam Police, who have been cured of coronavirus, have volunteered to donate plasma.